15301324

Source:http://linkedlifedata.com/resource/pubmed/id/15301324

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0009462, umls-concept:C0027051, umls-concept:C0032893, umls-concept:C0087111, umls-concept:C0681685, umls-concept:C1521761
pubmed:issue	8
pubmed:dateCreated	2004-8-10
pubmed:abstractText	To examine secular trends in the use of evidence-based therapies in a geographically defined cohort of patients with myocardial infarction (MI) and to test the hypotheses that baseline use is increasing and that disparities in use are diminishing,
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/AR30582, http://linkedlifedata.com/resource/pubmed/grant/R01HL59205
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/15301324-15301321
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0405543
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme..., http://linkedlifedata.com/resource/pubmed/chemical/Aspirin, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolytic Agents
pubmed:status	MEDLINE
pubmed:month	Aug
pubmed:issn	0025-6196
pubmed:author	pubmed-author:JacobsenSteven JSJ, pubmed-author:KillianJill MJM, pubmed-author:PerschbacherJames MJM, pubmed-author:ReederGuy SGS, pubmed-author:RogerVéronique LVL, pubmed-author:SlobodovaAdrianaA, pubmed-author:WestonSusan ASA
pubmed:issnType	Print
pubmed:volume	79
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	983-91
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:15301324-Adrenergic beta-Antagonists, pubmed-meshheading:15301324-Age Factors, pubmed-meshheading:15301324-Aged, pubmed-meshheading:15301324-Angiotensin-Converting Enzyme Inhibitors, pubmed-meshheading:15301324-Aspirin, pubmed-meshheading:15301324-Comorbidity, pubmed-meshheading:15301324-Drug Utilization, pubmed-meshheading:15301324-Evidence-Based Medicine, pubmed-meshheading:15301324-Female, pubmed-meshheading:15301324-Fibrinolytic Agents, pubmed-meshheading:15301324-Health Services Research, pubmed-meshheading:15301324-Humans, pubmed-meshheading:15301324-Logistic Models, pubmed-meshheading:15301324-Male, pubmed-meshheading:15301324-Middle Aged, pubmed-meshheading:15301324-Minnesota, pubmed-meshheading:15301324-Myocardial Infarction, pubmed-meshheading:15301324-Myocardial Reperfusion, pubmed-meshheading:15301324-Physician's Practice Patterns, pubmed-meshheading:15301324-Proportional Hazards Models, pubmed-meshheading:15301324-Retrospective Studies, pubmed-meshheading:15301324-Severity of Illness Index, pubmed-meshheading:15301324-Sex Factors
pubmed:year	2004
pubmed:articleTitle	Evidence-based therapies for myocardial infarction: secular trends and determinants of practice in the community.
pubmed:affiliation	Department of Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minn 55905, USA.
pubmed:publicationType	Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't